Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site


Demographic Characteristics of Benzodiazepine-involved
Emergency Department Visits

The DAWN Report:  Demographic Characteristics of Benzodiazepine-involved ED Visits (PDF format)

Highlights:
  • Benzodiazepines are psychotherapeutic sedatives used to treat anxiety, insomnia, and seizures. SAMHSA's DAWN found that benzodiazepines were involved in 100,784 drug abuse related emergency department visits in 2002 and were the most frequently reported type of psychotherapeutic drug.
  • From 1995 to 2002, drug abuse related emergency department visits involving benzodiazepines increased 41%.
  • Nearly half of the drug abuse related emergency department visits involving benzodiazepines were the result of suicide attempts.
  • Suicide related visits involving benzodiazepines have been stable since 1995, but visits attributed to drug dependence and drug taking for psychic effects have been increasing. 

Data on Other Specific Drugs

Other Topics

Other OAS Publications and Services

This Short Report, The DAWN Report:  Demographic Characteristics of Benzodiazepine-involved ED Visits (PDF format), is based on the Drug Abuse Warning Network (DAWN), the primary source of national data on drug related emergency department visits.  DAWN is conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA).  

This is the page footer.

This page has been accessed 88940 times since 8/13/04.

This page was last updated on April 28, 2008.  

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

This is a line.

   Site Map | Contact Us | AccessibilityPrivacy PolicyFreedom of Information Act
 Disclaimer | Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* PDF formatted files require that Adobe Acrobat ReaderĀ® program is installed on your computer. Click here to download this FREE software now from Adobe.